MMV MEDICINES FOR MALARIA VENTURE NORTH AMERICA INC (EIN 270670085) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Principal Officer

Andrea Lucard

Tax Period

2020-01-01 to 2020-12-31

MMV MEDICINES FOR MALARIA VENTURE NORTH AMERICA INC, founded in 2010, is a small nonprofit in the Medical Research sector that reported $501K in total revenue in fiscal year 2020. Revenue surged 359% from the prior year, signaling strong growth momentum. Expenses of $607K exceeded revenue, resulting in a 21% operating deficit.

Mission

The Organization exists to administer and disburse funds to support the projects and programs of other nonprofit organizations that are dedicated to the treatment and prevention of malaria in disease-endemic countries.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2020)

Revenue Breakdown

Contributions & Grants $500,035

Program Service Revenue $0

Investment Income $876

Other Revenue $0

TOTAL REVENUE $500,911

Expense Breakdown

Grants Paid $607,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $607,000

Other Expenses $225

TOTAL EXPENSES $607,225

Year-over-Year Comparison

	2020	2019	Change
Revenue	$500,911	$109,146	+3.6%
Expenses	$607,225	$193	+3145.2%
Net Income	$-106,314	$108,953	-2.0%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Sylvie Fonteilles-Drabek	Director and Chair	1.00	Director	$0	$0	$0
Andrea Lucard	Director and President	1.00	Officer Director	$0	$0	$0
Dennis Schmatz	Director	1.00	Director	$0	$0	$0
Alan Court	Director	1.00	Director	$0	$0	$0
Andrea Buscaglia	Director	1.00	Director	$0	$0	$0
David Reddy	Director	1.00	Director	$0	$0	$0
Allison Neapole	Secretary	1.00	Officer	$0	$0	$0
Gregory Bonnaud	Treasurer	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2020	$500,911	$607,225	$87,255	$-106,314

MMV MEDICINES FOR MALARIA VENTURE NORTH AMERICA INC